Automate Your Wheel Strategy on CVS
With Tiblio's Option Bot, you can configure your own wheel strategy including CVS - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CVS
- Rev/Share 305.4036
- Book/Share 61.2567
- PB 1.1587
- Debt/Equity 1.0691
- CurrentRatio 0.8034
- ROIC 0.0353
- MktCap 89823130600.0
- FreeCF/Share 3.7757
- PFCF 18.7914
- PE 19.7877
- Debt/Assets 0.3202
- DivYield 0.0376
- ROE 0.0595
- Rating A-
- Score 4
- Recommendation Buy
- P/E Score 2
- DCF Score 5
- P/B Score 4
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CVS | UBS | Neutral | Buy | -- | $79 | Aug. 18, 2025 |
| Upgrade | CVS | Robert W. Baird | Neutral | Outperform | -- | $82 | Aug. 14, 2025 |
| Upgrade | CVS | Leerink Partners | Market Perform | Outperform | $55 | $75 | Feb. 13, 2025 |
| Upgrade | CVS | Cantor Fitzgerald | Neutral | Overweight | -- | -- | Feb. 12, 2025 |
| Upgrade | CVS | Edward Jones | Hold | Buy | -- | -- | Jan. 30, 2025 |
| Upgrade | CVS | Deutsche Bank | Hold | Buy | -- | $66 | Dec. 3, 2024 |
| Upgrade | CVS | Barclays | Equal Weight | Overweight | $63 | $82 | Oct. 10, 2024 |
| Upgrade | CVS | TD Cowen | Hold | Buy | $59 | $85 | Oct. 4, 2024 |
News
4 Value Stocks Every Investor Should Hold in Volatile Times
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
StoneCo, CVS, Integer Holdings and USANA emerge as attractive value stocks with low cash-flow ratios and solid growth outlooks.
Read More
Value Investing: 5 Undervalued Stocks Worth Adding to Your Portfolio
Published: August 21, 2025 by: Zacks Investment Research
Sentiment: Positive
StoneCo, CVS Health, KT, KB Financial and USANA Health stand out as undervalued picks with low P/B ratios and solid growth prospects.
Read More
Should You Invest in CVS Health (CVS) Based on Bullish Wall Street Views?
Published: August 20, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
CVS unit must pay $290 million in drug whistleblower lawsuit, judge rules
Published: August 20, 2025 by: Reuters
Sentiment: Negative
A federal judge ordered CVS Health's pharmacy benefit manager unit to pay $289.9 million in damages and penalties after it overcharged Medicare for prescription drugs.
Read More
CVS Health upgraded by UBS on strong execution, margin improvement
Published: August 18, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) has been upgraded by UBS analysts who cited greater confidence in the company's recovery trajectory and multiple levers for earnings growth. The analysts upped their rating to ‘Buy' from ‘Neutral' and raised their price objective to $79 from $67, implying upside from its share price on Monday afternoon of about $70.
Read More
Investors Heavily Search CVS Health Corporation (CVS): Here is What You Need to Know
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
Read More
CVS Health: Outlier In Healthcare Implosion - Further Margin Recovery Ahead
Published: August 18, 2025 by: Seeking Alpha
Sentiment: Positive
CVS has emerged as an outlier during the ongoing implosion observed in the healthcare insurance sector, as they drive improved YoY margins despite the rising medical costs. This is on top of the somewhat stable performance metrics observed in the PBM and pharmacy end markets, as the management confidently raises the FY2025 adj EPS guidance. These directly contrast the massive pessimism observed in CVS' healthcare peers, where CEO is being replaced and FY2025 guidance has been cut/ suspended.
Read More
CVS Advances Digital Efforts to Simplify Healthcare Experience
Published: August 14, 2025 by: Zacks Investment Research
Sentiment: Neutral
CVS Health commits $20B to build an open health platform, joining tech giants in a push to streamline patient care access nationwide.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical Services stocks have likely encountered both CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
3 Strong Buy High-Yield Dividend Stocks With Over 40% Upside Potential
Published: August 11, 2025 by: 24/7 Wall Street
Sentiment: Positive
Investors love dividend stocks, especially those with high yields, because they provide a substantial income stream and offer significant total return potential.
Read More
5 Low Price-to-Book Stocks to Add to Your Portfolio in August
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
STNE, CVS, KT, KB and USNA stand out in August for low P/B ratios and strong growth forecasts, making them value stock contenders.
Read More
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
CVS Lifts 2025 Adjusted EPS Forecast Again: What's Driving the Move?
Published: August 05, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health boosts 2025 EPS guidance again as Health Care Benefits and PBM businesses drive growth.
Read More
4 Value Stocks to Shield Amid Labor Market and Trade Worries
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Negative
CVS, ITGR, ASB and FNB emerge as value picks amid trade tensions and labor market concerns, thanks to strong cash flow metrics.
Read More
Is It Worth Investing in CVS Health (CVS) Based on Wall Street's Bullish Views?
Published: August 04, 2025 by: Zacks Investment Research
Sentiment: Neutral
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
CVS Health tops Q2 estimates, lifts full-year guidance
Published: July 31, 2025 by: Proactive Investors
Sentiment: Positive
CVS Health Corp (NYSE:CVS) reported better-than-expected financial results for the second quarter, driven by robust growth across its retail pharmacy, insurance (Aetna), and health services segments. Total revenue was up 8.4% at $98.9 billion, above Wall Street estimates of $94.7 billion.
Read More
PCE Comes in Warmer Than Expected
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
PCE Comes in Warmer Than Expected.
Read More
Economy Heating Up on PCE for June
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
Pre-market and bond yield numbers appear to be in reaction to this morning's economic posts.
Read More
CVS Stock Up on Q2 Earnings & Revenue Beat, '25 EPS View Raised
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.
Read More
CVS Health (CVS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for CVS Health (CVS) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
CVS Health Stock Surges After Earnings Smash Forecasts. A Value Play Has Become a Rally.
Published: July 31, 2025 by: Barrons
Sentiment: Positive
The company boosts its full-year guidance range for adjusted earnings on the heels of a strong second quarter.
Read More
63 July Fortune 500 Industry Leaders: 3 Ideal "Safer" Dividend Buys
Published: July 30, 2025 by: Seeking Alpha
Sentiment: Positive
Three Fortune 500 Industry Leaders—Energy Transfer, Verizon, and World Kinect—currently meet the ideal 'dogcatcher' standard for fair-priced, safer dividend stocks. Analyst projections suggest the top ten F500IL 'dogs' could yield 15.1% to 34.8% net gains by July 2026, with lower-than-market volatility. Most high-yield F500IL stocks remain overpriced, but a market correction or dividend increases could bring more into ideal buy territory.
Read More
Is CVS Health (CVS) Stock Outpacing Its Medical Peers This Year?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Here is how CVS Health (CVS) and Agenus (AGEN) have performed compared to their sector so far this year.
Read More
CVS Health Care Delivery: Will the Growth Momentum Last in Q2?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS' Health Care Delivery unit posts strong growth from Signify and Oak Street, but rising medical costs pose a near-term risk.
Read More
Buy CVS Stock Ahead of Its Upcoming Earnings?
Published: July 30, 2025 by: Forbes
Sentiment: Neutral
CVS Health (NYSE:CVS) is scheduled to announce its earnings on Thursday, July 31, 2025. For event-driven traders, analyzing the stock's historical behavior around earnings releases can provide valuable context.
Read More
Here's Why CVS Health (CVS) is a Strong Value Stock
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Visa, CVS, and 4 More Oversold Stocks Worth a Look Before Earnings
Published: July 25, 2025 by: Barrons
Sentiment: Positive
Stocks that have gained too much are more susceptible to big drops than companies that dropped heading into their results.
Read More
CVS or DHR: Which Is the Better Value Stock Right Now?
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical Services stocks are likely familiar with CVS Health (CVS) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
Read More
CVS Health (CVS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
CVS Health (CVS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
About CVS Health Corporation (CVS)
- IPO Date 1996-11-20
- Website https://www.cvshealth.com
- Industry Medical - Healthcare Plans
- CEO J. David Joyner CEBS
- Employees 219000